Ann Michelini

Author PubWeight™ 12.56^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.	J Clin Oncol	2006	2.80
2	Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.	J Clin Oncol	2006	1.86
3	Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.	J Clin Oncol	2006	1.64
4	A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.	Dig Dis Sci	2006	1.09
5	Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.	Cancer Invest	2007	0.99
6	A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.	Cancer	2004	0.94
7	The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.	Am J Clin Oncol	2006	0.86
8	Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.	Cancer Chemother Pharmacol	2007	0.81
9	A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.	Cancer Invest	2006	0.79
10	A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.	Cancer Invest	2006	0.79